BSE filing, NSE: GLAND. Summary written from the filing by ALFA Finder's alert engine.
Gland Pharma Ltd: key numbers
- Share price
- ₹3,049.00
- Market cap
- ₹50,312 Cr
- Revenue (annual)
- ₹6,431 Cr
- Net profit (annual)
- ₹1,027 Cr
- P/E (TTM)
- 44.6×Sector 46.1×
- Promoter holding
- 45.75%-6.02% QoQ
- FII holding
- 10.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gland Pharma Ltd
All →Gland Pharma Business Update
Gland Pharma reports that USFDA concluded an unannounced cGMP inspection at its Dundigal formulation facility with four procedural Form 483 observations. No monetary impact is stated, and corrective actions will be submitted within the stipulated period.
Gland Pharma Board Meeting Date
Gland Pharma Ltd scheduled a board meeting for November 06, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ending September 30, 2026.
Gland Pharma Other Announcement
Gland Pharma Limited has filed the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Gland Pharma Annual General Meeting
Gland Pharma issued a postal ballot notice to seek shareholder approval for appointing Mr. Xingli Wang as Non-Executive Director. E-voting runs October 7 to November 5, 2026.
Gland Pharma Management Change
Gland Pharma Limited announced the resignation of director Wenjie Zhang and the appointment of Xingli Wang as a Non-Executive Non-Independent Director effective October 1, 2026.
Gland Pharma Acquisition Worth ₹199.5 Cr
Gland Pharma Limited's board approved a USD 21 million investment in its subsidiary, Gland USA, to acquire a 60% stake in Novelstar Pharma Inc. This acquisition facilitates business expansion in the USA.
- Value
- ₹199.5 Cr
- Execution
- By October 31, 2026
Other promoter selling announcements
All →Mukta Agriculture Promoter Selling: ₹0.15 Cr
Mukta Agriculture promoter Krishan Khadaria sold 2,00,000 shares on BSE for ₹0.15 Crore. His stake reduced from 2.37% to 1.45%.
- Value
- ₹0.15 Cr
- Promoter stake change
- -0.92%
Karur Vysya Bank Promoter Selling: ₹0.93 Cr
Promoter A J Suriyanarayana sold 25,000 Karur Vysya Bank shares on the market on 19 October 2026. The trade was valued at Rs.0.93 Crore.
- Value
- ₹0.93 Cr
Mukta Agriculture Promoter Selling: ₹0.14 Cr
Promoter Krishan Khadaria sold 2,00,000 equity shares of Mukta Agriculture on the BSE market on 23 October 2026. His holding fell from 3.30% to 2.37%, for a stated value of Rs 14,28,000.
- Value
- ₹0.14 Cr
- Promoter stake change
- -0.93%
Mukta Agriculture Promoter Selling
Promoter Mohit Khadaria sold 3,912 equity shares (0.02%) of Mukta Agriculture in the open market on 23 October 2026, exiting to a NIL holding.
Granules India Promoter Selling
Promoter Dr Krishna Prasad Chigurupati filed a revised disclosure of selling 1,72,00,000 Granules India shares on 11 September 2026. Promoter group voting stake falls from 38.02% to 31.08%.
Gallantt Ispat Promoter Selling: ₹149.8 Cr
Gallantt Industry Private Limited, a promoter group entity, sold its entire 2,651,975 shares (1.10%) in Gallantt Ispat via NSE block deal on October 22, 2026. Post-sale holding is nil.
- Value
- ₹149.8 Cr
- Promoter stake change
- -1.10%